Benylin Chesty Coughs Non-Drowsy

Benylin is a well-known brand of cough suppresses and expectorants, primarily marketed in the United Kingdom, Ireland, and South Africa. Originally developed as a prescription-only medication containing diphenhydramine, it has evolved into a comprehensive range of over-the-counter remedies for various types of coughs and cold symptoms.

The brand has a long corporate history, starting with Parke-Davis, an American pharmaceutical company founded in Detroit. After several acquisitions, the consumer health division of Warner-Lambert (which had acquired Parke-Davis) was bought by Pfizer, and subsequently, most of Pfizer's consumer brands were sold to Johnson & Johnson. In 2023, Johnson & Johnson completed a spin-off of its consumer health business into a new independent entity called Kenvue.

Today, Benylin is manufactured in various locations across Europe and other territories to meet regional demand. While the brand remains deeply rooted in the UK market, its ultimate ownership resides with the American consumer health giant Kenvue, which is headquartered in New Jersey, USA.